Darwin Nunez future in doubt after forward REJECTS offer
Liverpool are known to be open to selling Darwin Nunez this summer. The Reds entertained bids for the Uruguayan in the winter window - but ultimately opted against releasing him.
Back then a lack of alternatives in the market scuppered any plans for a sale but the picture now looks different. There are several star names available - ranging from Victor Osimhen and Hugo Ektike to Joao Pedro and Alexander Isak.
Advertisement
But firstly sporting director Richard Hughes must earn the right money on Darwin. Acquired for a fee that could have eventually reached £85 million from Benfica back in 2022, Nunez is reportedly available at closer to £60m.
That looks like a hefty price - but given the 25-year-old's experience, track record and current contract (2028), it's probably in line with other market values.
And now it would appear that three clear suitors are emerging for the title-winning No9. We have AC Milan, Napoli and Al-Hilal.
But which destination looks most likely destination for Darwin?
Can AC Milan afford Darwin Nunez?
AC Milan suffered a poor season in Serie A - finishing down in eighth place - and are seeking rejuvenation in the summer window. Nunez is a long-time club favourite - and this could be the right time for the Rossoneri to strike.
Advertisement
However, Milan are going to have trouble affording the South American frontman. According to a recent report in Empire of the Kop, the Milanese giants are seeking only a loan deal - which won't ultimately solve Liverpool's problems.
Getting rid of Nunez isn't the issue; the club would like to reinvest the proceeds of his sale into another forward option. A loan isn't a lot of use. So let's discount Milan at this stage.
© IMAGO - Darwin Nunez Liverpool 2024-25
Napoli want loan deal for Darwin Nunez
Then we have to consider Napoli.
The Serie A winners - coached by Antonio Conte - are looking to reduce their reliance on Romelu Lukaku up front and reportedly see Darwin as the ideal candidate.
Advertisement
Having sold Khvicha Kvaratskhelia to Paris Saint-Germain in January - and now banking even more prize money and Champions League participation fees - the Neapolitan club are relatively flush.
Conte's club CAN afford Darwin at his current asking price but they too would prefer a loan agreement and - according to EOTK - don't necessarily want to include a purchase obligation.
© IMAGO
Darwin Nunez rejects Al-Hilal
Al-Hilal, therefore, can be brought to the table at this point.
The Saudi Arabian side will have no issue in affording the transfer fee and they could probably increase Darwin's reported Liverpool salary of £140k per week many times over.
Advertisement
But the problem for Al-Hilal is that he's already turned them down. At this stage of his career, a top-level club in Europe is what he is seeking.
Maybe Al-Hilal will come into focus later in the window in the event that Darwin doesn't attract the right bids from clubs in Europe. But for now, it looks like they can be counted out too.
© IMAGO - Arne Slot Richard Hughes Liverpool
Darwin Nunez - Victor Osimhen swap deal?
There is no easy solution for Richard Hughes and Arne Slot right now. It looks like Darwin's criteria would be satisfied by a move to Napoli but it would require a shift in their stance.
They will need to put money on the table - either in the form of a straight-up cash deal or else a loan with a permanent transfer obligation at the end of it.
Maybe the Reds will succeed in talking Napoli into the kind of deal they want - or else discuss a swap deal involving Osimhen. They need the Nigerian off the books and he's valued around the same as Darwin considering his contract expires in 2026.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
FTSE 100 LIVE: Stocks rise as UK inflation slows ahead of Bank of England decision
The FTSE 100 (^FTSE) and European stocks climbed higher on Wednesday as UK inflation slowed to 3.4% in May amid an easing of transport costs. This was down from 3.5% in April, according to the Office for National Statistics, in line with City economists' forecasts but well above the central bank's 2% target. Transport prices rose by 0.7% in the 12 months to May, down from 3.3% in the year to April, reflecting drops in air fares (which jumped in April) and petrol prices, together with the correction of an error in vehicle excise duty prices. The largest downward contribution came from transport while upward momentum came from food, and furniture and household goods, the ONS said. Core inflation, which excludes food and energy, softened, falling from 3.8% to 3.5% — again matching forecasts. Money Markets still expect the Bank of England to hold interest rates on Thursday, with traders pencilling in a 10% chance of a cut. A reduction in August seems more likely and the City is still expecting two more quarter-point cuts to the base rate by the end of the year, from its current 4.25%. London's benchmark index (^FTSE) was 0.2% higher in early trade Germany's DAX (^GDAXI) rose 0.2% and the CAC (^FCHI) in Paris also headed 0.2% into the green The pan-European STOXX 600 (^STOXX) was treading water after opening Wall Street is set for a positive start as S&P 500 futures (ES=F), Dow futures (YM=F) and Nasdaq futures (NQ=F) were all in the green. The pound was 0.2% higher against the US dollar (GBPUSD=X) at 1.3466 Follow along for live updates throughout the day: Rachel Reeves has said she knows there is 'more to do' as the inflation figure came in well above the Bank of England's 2% target. The chancellor said on Wednesday: Meanwhile, the shadow chancellor Sir Mel Stride, from the opposition Conservative party, said: Transport costs eased last month, pushing overall inflation lower. This was the largest downward contribution partially offsetting upward contributions from food, and furniture and household goods. The average price of petrol dropped by 2.1p between April and May to 132.4p per litre, compared with 148.8p in May 2024. Diesel prices fell 2.6p to 139.1p per litre, down from 156.3p a year earlier. Food and non-alcoholic drink prices picked up. Inflation in this category rose to 4.4% in the 12 months to May, up from 3.4% in April — the highest rate since February 2024, when it stood at 5%. The ONS said that the prices of chocolate, confectionery and ice cream rose between April and May but fell between the same months a year ago. It also said that meat prices rose by more this year than during the same period of 2024. ONS acting chief economist Richard Heys said: UK inflation fell to 3.4% in May, in line with economists' expectations, offering fresh evidence that price pressures may be starting to ease as the Bank of England prepares to announce its latest interest rate decision. The drop comes after inflation hit a 14-month high of 3.5% in April, driven by a wave of household bill increases. However, the Office for National Statistics (ONS) said an error in vehicle tax data meant April's inflation rate should have been 3.4%. Despite the mistake, the ONS has not issued an official revision. Core inflation, which excludes food and energy, also softened, falling from 3.8% to 3.5% — again matching forecasts. The statistics office said transport prices rose by 0.7% in the 12 months to May, down from 3.3% in the 12 months to April, reflecting drops in air fares (which jumped in April) and petrol prices, together with the correction of the error in vehicle excise duty prices. The latter was overstated in April and the series corrected from May. As is standard practice, the April figure has not been revised, the ONS said. Asian equity markets were mixed overnight, with the Hang Seng index (^HSI) leading the losses in the region, declining 1.1%. The Shanghai Composite ( was treading water while the Nikkei (^N225) defied the regional trend, advancing 0.9% to a four-month high, supported by a weaker yen. It came as Japan's exports in May fell 1.7% year-on-year, marking the most significant decline since September 2024, as the nation continues to face trade uncertainties. This drop was less severe than the 3.7% fall anticipated by Bloomberg, but represents a reversal from the 2.0% increase recorded in April. Japan's trade deficit swelled to -637.6bn yen in May, which is smaller than the expected -896.5bn yen, compared to a revised deficit of -115.6bn yen the previous month. Meanwhile the Kospi (^KS11) also made gains, up 0.7% on the day. Across the pond on Wall Street, the US dollar held onto most of its gains against its peers but stocks stayed under pressure. The Dow Jones (^DJI) finished 0.7% lower, at 42,215.80, and the S&P 500 (^GSPC) fell 0.8% to 5,982.72. Apart from energy, all the major sector groups lost ground, including the Magnificent 7 (-1.06%). The tech-heavy Nasdaq (^IXIC) shed 0.9%, closing at 19,521.09. One of the negative drivers on Tuesday was underwhelming US data across the board. Retail sales fell 0.9% in May, compared to the 0.6% fall expected, which was a second consecutive monthly decline. Industrial production also fell 0.2% in May (versus an expected no change). However, some of the core measures fared better, and the retail control group was up 0.4%, compared to the 0.3% expected. In the bond market, the yield on benchmark 10-year US Treasury notes dropped to 4.389% last night, from 4.454% late on Monday. Good morning, and welcome back to our markets live blog. As usual we will be taking a deep dive into what's moving markets and happening across the global economy. For the day ahead, the main highlight will be the Federal Reserve's latest policy decision, along with chair Powell's subsequent press conference. Data releases include US housing starts and building permits for May, the weekly initial jobless claims, and the UK CPI print for May. ECB speakers include Elderson, Escriva, Villeroy, Knot, Panetta, Nagel, Centeno and Lane. Here's a snapshot of what's on the agenda: G-7 leaders meeting day 2 7am: UK inflation data 9.30am: UK house prices and rents 10am: Eurozone inflation (final) for May 12pm: US MBA Mortgage Applications 1.30pm: US Housing starts for May and initial jobless claims 7pm: US Federal Reserve interest rate decision (no change expected)Rachel Reeves has said she knows there is 'more to do' as the inflation figure came in well above the Bank of England's 2% target. The chancellor said on Wednesday: Meanwhile, the shadow chancellor Sir Mel Stride, from the opposition Conservative party, said: Transport costs eased last month, pushing overall inflation lower. This was the largest downward contribution partially offsetting upward contributions from food, and furniture and household goods. The average price of petrol dropped by 2.1p between April and May to 132.4p per litre, compared with 148.8p in May 2024. Diesel prices fell 2.6p to 139.1p per litre, down from 156.3p a year earlier. Food and non-alcoholic drink prices picked up. Inflation in this category rose to 4.4% in the 12 months to May, up from 3.4% in April — the highest rate since February 2024, when it stood at 5%. The ONS said that the prices of chocolate, confectionery and ice cream rose between April and May but fell between the same months a year ago. It also said that meat prices rose by more this year than during the same period of 2024. ONS acting chief economist Richard Heys said: UK inflation fell to 3.4% in May, in line with economists' expectations, offering fresh evidence that price pressures may be starting to ease as the Bank of England prepares to announce its latest interest rate decision. The drop comes after inflation hit a 14-month high of 3.5% in April, driven by a wave of household bill increases. However, the Office for National Statistics (ONS) said an error in vehicle tax data meant April's inflation rate should have been 3.4%. Despite the mistake, the ONS has not issued an official revision. Core inflation, which excludes food and energy, also softened, falling from 3.8% to 3.5% — again matching forecasts. The statistics office said transport prices rose by 0.7% in the 12 months to May, down from 3.3% in the 12 months to April, reflecting drops in air fares (which jumped in April) and petrol prices, together with the correction of the error in vehicle excise duty prices. The latter was overstated in April and the series corrected from May. As is standard practice, the April figure has not been revised, the ONS said. Asian equity markets were mixed overnight, with the Hang Seng index (^HSI) leading the losses in the region, declining 1.1%. The Shanghai Composite ( was treading water while the Nikkei (^N225) defied the regional trend, advancing 0.9% to a four-month high, supported by a weaker yen. It came as Japan's exports in May fell 1.7% year-on-year, marking the most significant decline since September 2024, as the nation continues to face trade uncertainties. This drop was less severe than the 3.7% fall anticipated by Bloomberg, but represents a reversal from the 2.0% increase recorded in April. Japan's trade deficit swelled to -637.6bn yen in May, which is smaller than the expected -896.5bn yen, compared to a revised deficit of -115.6bn yen the previous month. Meanwhile the Kospi (^KS11) also made gains, up 0.7% on the day. Across the pond on Wall Street, the US dollar held onto most of its gains against its peers but stocks stayed under pressure. The Dow Jones (^DJI) finished 0.7% lower, at 42,215.80, and the S&P 500 (^GSPC) fell 0.8% to 5,982.72. Apart from energy, all the major sector groups lost ground, including the Magnificent 7 (-1.06%). The tech-heavy Nasdaq (^IXIC) shed 0.9%, closing at 19,521.09. One of the negative drivers on Tuesday was underwhelming US data across the board. Retail sales fell 0.9% in May, compared to the 0.6% fall expected, which was a second consecutive monthly decline. Industrial production also fell 0.2% in May (versus an expected no change). However, some of the core measures fared better, and the retail control group was up 0.4%, compared to the 0.3% expected. In the bond market, the yield on benchmark 10-year US Treasury notes dropped to 4.389% last night, from 4.454% late on Monday. Good morning, and welcome back to our markets live blog. As usual we will be taking a deep dive into what's moving markets and happening across the global economy. For the day ahead, the main highlight will be the Federal Reserve's latest policy decision, along with chair Powell's subsequent press conference. Data releases include US housing starts and building permits for May, the weekly initial jobless claims, and the UK CPI print for May. ECB speakers include Elderson, Escriva, Villeroy, Knot, Panetta, Nagel, Centeno and Lane. Here's a snapshot of what's on the agenda: G-7 leaders meeting day 2 7am: UK inflation data 9.30am: UK house prices and rents 10am: Eurozone inflation (final) for May 12pm: US MBA Mortgage Applications 1.30pm: US Housing starts for May and initial jobless claims 7pm: US Federal Reserve interest rate decision (no change expected)
Yahoo
26 minutes ago
- Yahoo
Is It Too Late To Consider Buying Branicks Group AG (ETR:DIC)?
Branicks Group AG (ETR:DIC), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the past couple of months on the XTRA. While good news for shareholders, the company has traded much higher in the past year. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. But what if there is still an opportunity to buy? Today we will analyse the most recent data on Branicks Group's outlook and valuation to see if the opportunity still exists. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Great news for investors – Branicks Group is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is €2.66, but it is currently trading at €1.87 on the share market, meaning that there is still an opportunity to buy now. However, given that Branicks Group's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility. See our latest analysis for Branicks Group Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. In the upcoming year, Branicks Group's earnings are expected to increase by 93%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since DIC is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on DIC for a while, now might be the time to enter the stock. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy DIC. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy. So while earnings quality is important, it's equally important to consider the risks facing Branicks Group at this point in time. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Branicks Group. If you are no longer interested in Branicks Group, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
26 minutes ago
- Yahoo
Germany Legal Cannabis Market Report 2025-2030: Competitive Analysis of The Cronos Group, Organigram, Tilray, Canopy Growth, Aurora Cannabis, SynBiotic, Cansativa, Four 20 Pharma, and Avextra Pharma
Germany's legal cannabis market, valued at USD 37.15M in 2024, is expected to reach USD 85.64M by 2030, driven by rising acceptance, medical applications, and tech innovations. Key growth factors include government support, increased medical cannabis use, and advanced cultivation technologies. Ideal for market analysis and strategy planning. German Legal Cannabis Market Dublin, June 18, 2025 (GLOBE NEWSWIRE) -- The "Germany Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC, Others), End-use with Growth Forecasts, Key Companies and Competitive Analysis, 2025-2030" report has been added to German Legal Cannabis Market was valued at USD 37.15 million in 2024, and is projected to reach USD 85.64 million by 2030, rising at a CAGR of 14.09%. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany. Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy. In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany's biggest annual gathering of influential political and cannabis business cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast Legal Cannabis Market Report Highlights By source, the hemp segment dominated the market with the highest revenue share of 84.50% in 2024. Hemp covers an extensive range of products, including supplements, nutritional powders, beverages, protein & nutrition bars, animal feed, and pet food. By derivatives, the CBD segment dominated the market with the largest revenue share of 63.61% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health benefits. By end use, the industrial use segment dominated the market with a revenue share of 80.26% in 2024. This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Companies Featured The major companies featured in this Germany Legal Cannabis market report include: The Cronos Group Organigram Holding, Inc Tilray Brands Canopy Growth Corporation Aurora Cannabis SynBiotic Cansativa GmbH DEMECAN Four 20 Pharma Avextra Pharma Key Attributes: Report Attribute Details No. of Pages 150 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $37.15 Million Forecasted Market Value (USD) by 2030 $85.64 Million Compound Annual Growth Rate 14.0% Regions Covered Germany Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. Germany Legal Cannabis Market Variables, Trends, and Scope3.1. Market Lineage Outlook3.2. Germany Legal Cannabis Market - Market Dynamics3.3. Germany Legal Cannabis: Market Analysis Tools3.4. Current Market Trends in Cannabis Industry3.5. Regulatory Scenario3.6. Cannabis Consumption Pattern Analysis3.7. Guidelines and Requirements for Cannabis Cultivation3.8. Cannabis Facility Design and Equipment Requirements3.9. Reimbursement Policies in the GermanyChapter 4. Germany Legal Cannabis Market: Segment Analysis, By Source, 2018-2030 (USD Million)4.1. Definition and Scope4.2. Source Market Share Analysis, 2024 & 20304.3. Segment Dashboard4.4. Germany Legal Cannabis Market, by Source, 2018 to 20304.5. Marijuana4.5.1. Marijuana Market Estimates and Forecasts, 2018-2030 (USD Million)4.5.2. Flower4.5.3. Oil and Tinctures4.6. Hemp4.6.1. Hemp Market Estimates and Forecasts, 2018-2030 (USD Million)4.6.2. Hemp Oil4.6.3. Industrial HempChapter 5. Germany Legal Cannabis Market: Segment Analysis, By Derivative, 2018-2030 (USD Million)5.1. Definition and Scope5.2. Derivative Market Share Analysis, 2024 & 20305.3. Segment Dashboard5.4. Germany Legal Cannabis Market, by Derivative, 2018 to 20305.5. CBD5.6. THC5.7. OthersChapter 6. Germany Legal Cannabis Market: Segment Analysis, By End Use, 2018-2030 (USD Million)6.1. Definition and Scope6.2. End Use Market Share Analysis, 2024 & 20306.3. Segment Dashboard6.4. Germany Legal Cannabis Market, by End Use, 2018 to 20306.5. Medical Use6.5.1. Medical Market Estimates and Forecasts, 2018-2030 (USD Million)6.5.2. Cancer6.5.3. Chronic Pain6.5.4. Depression and Anxiety6.5.5. Arthritis6.5.6. Diabetes6.5.7. Glaucoma6.5.8. Migraines6.5.9. Epilepsy6.5.10. Multiple Sclerosis6.5.11. AIDS6.5.12. Amyotrophic Lateral Sclerosis6.5.13. Alzheimers's6.5.14. Post Traumatic Stress Disorder (PTSD)6.5.15. Parkinson's6.5.16. Tourettes6.5.17. Others6.6. Recreational Use6.7. Industrial UseChapter 7. Germany Legal Cannabis Market: Competitive Landscape7.1. Participant's Categorization7.2. Company Market Position Analysis, 20247.3. Strategy Mapping7.4. Company Profiles The Cronos Group Organigram Holding, Inc Tilray Brands Canopy Growth Corporation Aurora Cannabis SynBiotic Cansativa GmbH DEMECAN Four 20 Pharma Avextra Pharma For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment German Legal Cannabis Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
